Universe Pharmaceuticals INC (UPC)
USD 3.35
(-4.79%)
USD 3.35
(-4.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.16 Million USD | 29.46% |
| 2022 | -8.73 Million USD | -177.18% |
| 2021 | 11.31 Million USD | 49.77% |
| 2020 | 7.55 Million USD | 0.09% |
| 2019 | 7.55 Million USD | -0.68% |
| 2018 | 7.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -13.1 Million USD | 0.0% |
| 2023 Q4 | -5.44 Million USD | 0.0% |
| 2023 FY | -6.16 Million USD | 29.46% |
| 2023 Q2 | -715.42 Thousand USD | 0.0% |
| 2022 Q4 | -10.46 Million USD | 0.0% |
| 2022 FY | -8.73 Million USD | -177.18% |
| 2022 Q2 | 1.73 Million USD | 0.0% |
| 2021 FY | 11.31 Million USD | 49.77% |
| 2021 Q2 | 7.14 Million USD | 0.0% |
| 2021 Q4 | 4.17 Million USD | 0.0% |
| 2020 Q4 | 1.88 Million USD | 0.0% |
| 2020 FY | 7.55 Million USD | 0.09% |
| 2020 Q3 | 1.88 Million USD | 0.0% |
| 2020 Q2 | 1.88 Million USD | 0.0% |
| 2020 Q1 | 1.88 Million USD | 0.09% |
| 2019 Q2 | 1.88 Million USD | 0.0% |
| 2019 FY | 7.55 Million USD | -0.68% |
| 2019 Q4 | 1.88 Million USD | 0.0% |
| 2019 Q3 | 1.88 Million USD | 0.0% |
| 2018 Q3 | 1.9 Million USD | 0.0% |
| 2018 Q4 | 1.9 Million USD | 0.0% |
| 2018 Q2 | 1.9 Million USD | 0.0% |
| 2018 FY | 7.6 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 112.798% |
| Embecta Corp. | 70.4 Million USD | 108.754% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 132.819% |
| Dynavax Technologies Corporation | -6.38 Million USD | 3.536% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 97.055% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 114.69% |
| PainReform Ltd. | -9.34 Million USD | 34.043% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 21.689% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -36.773% |
| SCYNEXIS, Inc. | 67.04 Million USD | 109.193% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -98.903% |
| Cosmos Health Inc. | -18.54 Million USD | 66.763% |
| Journey Medical Corporation | -3.85 Million USD | -59.955% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -36.773% |
| Safety Shot Inc | -15.08 Million USD | 59.139% |
| Alpha Teknova, Inc. | -36.78 Million USD | 83.243% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 95.588% |
| Bright Green Corporation | -13.12 Million USD | 53.053% |
| Procaps Group, S.A. | 42.54 Million USD | 114.488% |
| Theratechnologies Inc. | -23.95 Million USD | 74.274% |
| Harrow Health, Inc. | -24.41 Million USD | 74.753% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -27.468% |
| Biofrontera Inc. | -20.13 Million USD | 69.385% |
| DURECT Corporation | -27.62 Million USD | 77.689% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 568.318% |
| Cronos Group Inc. | -73.96 Million USD | 91.667% |
| OptiNose, Inc. | -35.48 Million USD | 82.631% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 99.385% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 85.395% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 125.77% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 224.632% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 3999.857% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | 1.851% |
| Radius Health, Inc. | -25.79 Million USD | 76.104% |
| ProPhase Labs, Inc. | -16.78 Million USD | 63.276% |
| Phibro Animal Health Corporation | 2.41 Million USD | 355.094% |
| Procaps Group S.A. | 42.54 Million USD | 114.488% |
| Alvotech | -551.73 Million USD | 98.883% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 40.036% |
| Viatris Inc. | 54.7 Million USD | 111.267% |
| Rockwell Medical, Inc. | -8.43 Million USD | 26.969% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 61.102% |
| SIGA Technologies, Inc. | 68.06 Million USD | 109.054% |
| Tilray Brands, Inc. | -244.98 Million USD | 97.484% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 151.303% |
| Shineco, Inc. | -22.44 Million USD | 72.546% |
| PetIQ, Inc. | 2.13 Million USD | 389.21% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -43.266% |
| Incannex Healthcare Limited | -18.45 Million USD | 66.612% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 102.468% |
| Alimera Sciences, Inc. | -20.13 Million USD | 69.387% |
| Silver Spike Investment Corp. | 7.34 Million USD | 183.964% |
| Assertio Holdings, Inc. | -331.94 Million USD | 98.143% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | 6.517% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 24.502% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 65.568% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 69.273% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 96.155% |
| Hempacco Co., Inc. | -13.12 Million USD | 53.047% |
| Talphera, Inc. | -18.39 Million USD | 66.5% |
| Alvotech | -551.73 Million USD | 98.883% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 117.292% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 101.887% |
| Currenc Group, Inc. | -15.3 Million USD | 59.736% |
| Kamada Ltd. | 8.28 Million USD | 174.397% |
| Indivior PLC | 2 Million USD | 408.153% |
| Evoke Pharma, Inc. | -7.79 Million USD | 20.908% |
| Flora Growth Corp. | -57.03 Million USD | 89.194% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 69.273% |
| Evolus, Inc. | -61.68 Million USD | 90.009% |
| HUTCHMED (China) Limited | 100.78 Million USD | 106.115% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 104.481% |
| Akanda Corp. | -32.27 Million USD | 80.905% |